Nebraska Cancer Specialist

Omaha, Nebraska 68130-2042

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Cancer, MPN (Myeloproliferative Neoplasms), Prostate Cancer

Studies at this site

• A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer — Completed
• Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy — Completed
• Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer — Stopped early
• Study of PCUR-101 in Combination With ADT in Patients With mCRPC — Stopped early
• A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis — Completed